Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Prostate Cancer

  Free Subscription


20.03.2017

1 Acta Radiol
1 Am J Clin Oncol
1 Cancer
1 Cancer Res
3 Eur Urol
1 Hum Pathol
3 J Clin Oncol
2 J Nucl Med
2 Lancet Oncol
1 Magn Reson Imaging
2 Nat Rev Urol
3 Oncol Rep
1 Oncology (Williston Park)
1 PLoS One
1 Proc Natl Acad Sci U S A
1 Prostate
1 Urology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Radiol

  1. XIAOHANG L, Bingni Z, Liangping Z, Weijun P, et al
    Differentiation of prostate cancer and stromal hyperplasia in the transition zone with histogram analysis of the apparent diffusion coefficient.
    Acta Radiol. 2017 Jan 1:284185117698861. doi: 10.1177/0284185117698861.
    PubMed     Text format     Abstract available


    Am J Clin Oncol

  2. KISHAN AU, Duchesne G, Wang PC, Rwigema JM, et al
    Discord Among Radiation Oncologists and Urologists in the Postoperative Management of High-Risk Prostate Cancer.
    Am J Clin Oncol. 2017 Mar 15. doi: 10.1097/COC.0000000000000381.
    PubMed     Text format     Abstract available


    Cancer

  3. JACOBS BL, Yabes JG, Lopa SH, Heron DE, et al
    The early adoption of intensity-modulated radiotherapy and stereotactic body radiation treatment among older Medicare beneficiaries with prostate cancer.
    Cancer. 2017 Mar 16. doi: 10.1002/cncr.30574.
    PubMed     Text format     Abstract available


    Cancer Res

  4. MIAO L, Yang L, Li R, Nava Rodrigues D, et al
    Disrupting androgen receptor signaling induces Snail-mediated epithelial-mesenchymal plasticity in prostate cancer.
    Cancer Res. 2017 Mar 16. pii: canres.2169.2016.
    PubMed     Text format     Abstract available


    Eur Urol

  5. MURPHY DG, Sweeney CJ, Tombal B
    "Gotta Catch 'em All", or Do We? Pokemet Approach to Metastatic Prostate Cancer.
    Eur Urol. 2017 Mar 7. pii: S0302-2838(17)30131.
    PubMed     Text format     Abstract available

  6. ICZKOWSKI KA
    Re: Rodolfo Montironi, Silvia Gasparrini, Roberta Mazzucchelli, et al's Letter to the Editor re: Karim A. Touijer, James A. Eastham. The Sentinel Lymph Node Concept and Novel Approaches in Detecting Lymph Node Metastasis in Prostate Cancer. Eur Urol 2
    Eur Urol. 2017 Mar 8. pii: S0302-2838(17)30128.
    PubMed     Text format    

  7. MONTIRONI R, Lopez-Beltran A, Cheng L, Gasparrini S, et al
    Re: Kenneth A. Iczkowski's Letter to the Editor re: Re: Rodolfo Montironi, Silvia Gasparrini, Roberta Mazzucchelli, et al's Letter to the Editor re: Karim A. Touijer, James A. Eastham. The Sentinel Lymph Node Concept and Novel Approaches in Detecting
    Eur Urol. 2017 Mar 11. pii: S0302-2838(17)30127.
    PubMed     Text format    


    Hum Pathol

  8. HAMMERICH KH, Frolov A, Li R, Ittmann M, et al
    Cellular Interactions of The Phosphorylated Form of AKT in Prostate Cancer.
    Hum Pathol. 2017 Mar 11. pii: S0046-8177(17)30065.
    PubMed     Text format     Abstract available


    J Clin Oncol

  9. SAAD F
    Bone-Targeted Therapy in Prostate Cancer in 2017: Lost Opportunities, Confusion, and Controversy.
    J Clin Oncol. 2017 Mar 13:JCO2017722793. doi: 10.1200/JCO.2017.72.2793.
    PubMed     Text format    

  10. CATTON CN, Lukka H, Gu CS, Martin JM, et al
    Randomized Trial of a Hypofractionated Radiation Regimen for the Treatment of Localized Prostate Cancer.
    J Clin Oncol. 2017 Mar 15:JCO2016717397. doi: 10.1200/JCO.2016.71.7397.
    PubMed     Text format     Abstract available

  11. MASON MD, Clarke NW, James ND, Dearnaley DP, et al
    Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naive Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled Trial.
    J Clin Oncol. 2017 Mar 13:JCO2016690677. doi: 10.1200/JCO.2016.69.0677.
    PubMed     Text format     Abstract available


    J Nucl Med

  12. PIERT M, Shao X, Raffel DM, Davenport MS, et al
    Preclinical evaluation of 11C-sarcosine as a substrate of proton-coupled amino acid transporters and first human application in prostate cancer.
    J Nucl Med. 2017 Mar 16. pii: jnumed.116.173179. doi: 10.2967/jnumed.116.173179.
    PubMed     Text format     Abstract available

  13. GOFFIN KE, Joniau S, Tenke P, Slawin K, et al
    Phase 2 study of 99mTc-trofolastat SPECT/CT to identify and localize prostate cancer in intermediate- and high-risk patients undergoing radical prostatectomy and extended pelvic lymph node dissection.
    J Nucl Med. 2017 Mar 16. pii: jnumed.116.187807. doi: 10.2967/jnumed.116.187807.
    PubMed     Text format     Abstract available


    Lancet Oncol

  14. CHI KN, Higano CS, Blumenstein B, Ferrero JM, et al
    Custirsen in combination with docetaxel and prednisone for patients with metastatic castration-resistant prostate cancer (SYNERGY trial): a phase 3, multicentre, open-label, randomised trial.
    Lancet Oncol. 2017 Mar 7. pii: S1470-2045(17)30168.
    PubMed     Text format     Abstract available

  15. SONPAVDE G, Armstrong AJ
    Drug development in prostate cancer: time to embrace RECIST?
    Lancet Oncol. 2017 Mar 7. pii: S1470-2045(17)30149.
    PubMed     Text format    


    Magn Reson Imaging

  16. SKORPIL M, Brynolfsson P, Engstrom M
    Motion corrected DWI with integrated T2-mapping for simultaneous estimation of ADC, T2-relaxation and perfusion in prostate cancer.
    Magn Reson Imaging. 2017 Mar 9. pii: S0730-725X(17)30053.
    PubMed     Text format     Abstract available


    Nat Rev Urol

  17. STONE L
    Prostate cancer: Sending a signal through oncosomes.
    Nat Rev Urol. 2017 Mar 14. doi: 10.1038/nrurol.2017.
    PubMed     Text format    

  18. BRUINSMA SM, Roobol MJ, Carroll PR, Klotz L, et al
    Expert consensus document: Semantics in active surveillance for men with localized prostate cancer - results of a modified Delphi consensus procedure.
    Nat Rev Urol. 2017 Mar 14. doi: 10.1038/nrurol.2017.
    PubMed     Text format     Abstract available


    Oncol Rep

  19. JANG IS, Park JW, Jo EB, Cho CK, et al
    Growth inhibitory and apoptosis-inducing effects of allergen-free Rhus verniciflua Stokes extract on A549 human lung cancer cells.
    Oncol Rep. 2016;36:3037-3043.
    PubMed     Text format     Abstract available

  20. OHNISHI Y, Yasui H, Kakudo K, Nozaki M, et al
    Lapatinib-resistant cancer cells possessing epithelial cancer stem cell properties develop sensitivity during sphere formation by activation of the ErbB/AKT/cyclin D2 pathway.
    Oncol Rep. 2016;36:3058-3064.
    PubMed     Text format     Abstract available

  21. KIM TD, Shin S, Janknecht R
    ETS transcription factor ERG cooperates with histone demethylase KDM4A.
    Oncol Rep. 2016;35:3679-88.
    PubMed     Text format     Abstract available


    Oncology (Williston Park)

  22. MADDEN-FUENTES RJ, Peterson AC
    Pubic Bone Osteomyelitis and Pubosymphyseal Urinary Fistula: A Poorly Recognized Complication in Prostate Cancer Survivors.
    Oncology (Williston Park). 2017;31.
    PubMed     Text format    


    PLoS One

  23. MYUNG JK, Wang G, Chiu HH, Wang J, et al
    Inhibition of androgen receptor by decoy molecules delays progression to castration-recurrent prostate cancer.
    PLoS One. 2017;12:e0174134.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  24. BANERJEE S, Zare RN, Tibshirani RJ, Kunder CA, et al
    Diagnosis of prostate cancer by desorption electrospray ionization mass spectrometric imaging of small metabolites and lipids.
    Proc Natl Acad Sci U S A. 2017 Mar 14. pii: 201700677.
    PubMed     Text format     Abstract available


    Prostate

  25. JOSEFSSON A, Linder A, Flondell Site D, Canesin G, et al
    Circulating Tumor Cells as a Marker for Progression-free Survival in Metastatic Castration-naive Prostate Cancer.
    Prostate. 2017 Mar 10. doi: 10.1002/pros.23325.
    PubMed     Text format     Abstract available


    Urology

  26. CRAWFORD ED, Petrylak DP, Shore N, Saad F, et al
    The Role of Therapeutic Layering in Optimizing Treatment for Patients with Castration-Resistant Prostate Cancer (RADAR II).
    Urology. 2017 Mar 13. pii: S0090-4295(16)31023.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: